D-0329-2023 Class III Terminated

Recalled by Advantice Health, Llc — Cedar Knolls, NJ

FDA drug recall D-0329-2023 was initiated by Advantice Health, Llc on Feb 2, 2023 and is designated Class III. Reason for recall: Subpotent Drug: Low assay observed in one of the two active ingredients during stability testing. The recall status is terminated (terminated Oct 31, 2023). Affected quantity: 16,152 cans/673 cases.

Recall details

Product Type
Drugs
Report Date
Mar 1, 2023
Initiation Date
Feb 2, 2023
Termination Date
Oct 31, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,152 cans/673 cases

Product description

Dermoplast FIRST AID ANTIBACTERIAL SPRAY (Benzethonium chloride 0.2% First aid antiseptic, Benzocaine 20%) Topical analgesic, NET WT. 2.75 oz (78 g), Distributed by Advantice Health, LLC Cedar Knolls, NJ 07927, NDC# 16864-670-01

Reason for recall

Subpotent Drug: Low assay observed in one of the two active ingredients during stability testing.

Distribution pattern

Product was distributed via the internet, distributors and retailers nationwide.

Code information

Lot # 22336A

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0329-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0329-2023. Report a data issue: hello@regdatalab.com.